I’m confused about project funding for early stage works. They are reporting that capital from debt will land in Q2-Q3 2023. The project gantt chart has Procurement starting in Feb 2023 - several months prior to confirming debt agreements.
I’m very confident QPM can obtain funds for this project. But the timing of funds and debt commitments early on are a little confusing.
Anyone else share the same? Or is there a reasonable explanation I’m missing?
- Forums
- ASX - By Stock
- QPM
- Ann: TECH Project Feasibility Study (amended)
Ann: TECH Project Feasibility Study (amended), page-9
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QPM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.5¢ |
Change
0.002(6.06%) |
Mkt cap ! $90.75M |
Open | High | Low | Value | Volume |
3.5¢ | 3.6¢ | 3.3¢ | $145.0K | 4.180M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 590066 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 768225 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 583713 | 0.035 |
5 | 466716 | 0.034 |
13 | 1460334 | 0.033 |
12 | 3282761 | 0.032 |
8 | 1614925 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 768225 | 8 |
0.037 | 772946 | 4 |
0.038 | 598000 | 3 |
0.039 | 642860 | 3 |
0.040 | 1052040 | 4 |
Last trade - 13.51pm 15/07/2024 (20 minute delay) ? |
Featured News
QPM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online